Tissue Engineering and Cell Therapy Group, Singapore Eye Research Institute, Singapore, Singapore.
Duke-NUS Medical School, Ophthalmology and Visual Sciences Academic Clinical Programme, Singapore, Singapore.
Int Ophthalmol. 2021 May;41(5):1965-1979. doi: 10.1007/s10792-021-01745-w. Epub 2021 Feb 20.
Femtosecond lasers have revived the possibility of stromal keratophakia or tissue additive keratoplasty, a technique originally introduced by Prof. Jose Ignacio Barraquer in the 1960s. The surgical technique offers a unique solution to treat keratoconus. In the current study, we reviewed and performed a meta-analysis of the clinical outcomes of the femtosecond laser-assisted stromal keratophakia in the treatment of keratoconus.
This is a systematic review and meta-analysis of the estimated outcome difference between pre- and post-lenticule implantations.
A total of related 10 studies were found in the literature. No studies reported adverse events, such as persistent haze or graft rejection, at last patients' visits. We further narrowed down the article selection in accordance to our inclusion criteria to report the composite outcomes (9 studies) and meta-analysis (4 studies). In the composite analysis, we demonstrated that lenticule implantation in keratoconus and post-LASIK ectasia patients appeared to expand the stromal volume of the thin corneas, flattened the cones, and significantly improved uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA) and spherical equivalent (SE). The meta-analysis showed that the random estimated UCVA, BCVA, SE and mean keratometry (K) differences following the lenticule implantation was -0.214 (95% CI: -0.367 to 0.060; p = 0.006), -0.169 (-0.246 to 0.091; p < 0.001), -2.294 D (-3.750 to -0.839 D; p = 0.002), and 2.909 D (0.805 to 5.012 D; p = 0.007), respectively.
Femtosecond laser-assisted stromal keratophakia is a feasible technique to correct the refractive aberrations, expand corneal volume and regularize corneal curvature in patients with keratoconus. However, there is a need to standardize the technique (e.g., whether to crosslink or not or to use convex or concave lenticules) and to formulate a mathematical model that accounts for the long-term epithelial thickness changes and stromal remodeling to determine the shape or profile of the lenticules, in order to improve the efficacy of the keratophakia further.
飞秒激光使基质角膜磨镶术或组织添加剂角膜成形术成为可能,这是 20 世纪 60 年代何塞·伊格纳西奥·巴拉克尔教授最初引入的技术。该手术技术为治疗圆锥角膜提供了独特的解决方案。在本研究中,我们对飞秒激光辅助基质角膜磨镶术治疗圆锥角膜的临床结果进行了回顾和荟萃分析。
这是一项系统评价和荟萃分析,评估了透镜植入前后的预期结果差异。
在文献中总共找到了 10 项相关研究。最后一次就诊时,没有研究报告不良事件,如持续混浊或移植物排斥。我们根据纳入标准进一步缩小了文章选择范围,以报告综合结果(9 项研究)和荟萃分析(4 项研究)。在综合分析中,我们证明了在圆锥角膜和 LASIK 后扩张患者中植入透镜似乎可以扩大薄角膜的基质体积,使圆锥变平,并显著提高未矫正视力(UCVA)、最佳矫正视力(BCVA)和等效球镜(SE)。荟萃分析显示,透镜植入术后随机估计的 UCVA、BCVA、SE 和平均角膜曲率(K)差异分别为-0.214(95%CI:-0.367 至 0.060;p=0.006)、-0.169(-0.246 至 0.091;p<0.001)、-2.294 D(-3.750 至-0.839 D;p=0.002)和 2.909 D(0.805 至 5.012 D;p=0.007)。
飞秒激光辅助基质角膜磨镶术是一种可行的技术,可以矫正屈光不正、扩大角膜体积并使圆锥角膜患者的角膜曲率正常化。然而,需要标准化技术(例如,是否交联或使用凸或凹透镜)并制定考虑长期上皮厚度变化和基质重塑的数学模型,以确定透镜的形状或轮廓,从而进一步提高角膜磨镶术的疗效。